Gentian violet: a 19th century drug re‐emerges in the 21st century

AM Maley, JL Arbiser - Experimental dermatology, 2013 - Wiley Online Library
Gentian violet (GV) has a long and varied history as a medicinal agent. Historically used as
an antibacterial and antifungal, recent reports have shown its utility as an antitypranosomal …

[HTML][HTML] Pathogenesis of port-wine stains: directions for future therapies

L Liu, X Li, Q Zhao, L Yang, X Jiang - International journal of molecular …, 2022 - mdpi.com
Port-wine stains (PWSs) are congenital vascular malformations that involve the skin and
mucosa. To date, the mechanisms underlying the pathogenesis and progression of PWSs …

Topical rapamycin combined with pulsed dye laser in the treatment of capillary vascular malformations in Sturge-Weber syndrome: phase II, randomized, double-blind …

L Marqués, JM Núñez-Córdoba, L Aguado… - Journal of the American …, 2015 - Elsevier
Background Sturge-Weber syndrome (SWS) is characterized by port-wine stains (PWS)
affecting the face, eyes, and central nervous system. Pulsed dye laser (PDL) is the standard …

Applications of Graphene Family Nanomaterials in Regenerative Medicine: Recent Advances, Challenges, and Future Perspectives

X Chen, M Zou, S Liu, W Cheng, W Guo… - International Journal of …, 2024 - Taylor & Francis
Graphene family nanomaterials (GFNs) have attracted considerable attention in diverse
fields from engineering and electronics to biomedical applications because of their …

Sturge-weber syndrome

CD Bachur, AM Comi - Current treatment options in neurology, 2013 - Springer
Opinion statement We try to see the babies prior to the onset of symptoms so that their
parents can receive anticipatory guidance regarding seizures and how to recognize and …

Advances in the therapeutic use of mammalian target of rapamycin (mTOR) inhibitors in dermatology

AL Fogel, S Hill, JMC Teng - Journal of the American Academy of …, 2015 - Elsevier
Significant developments in the use of mammalian target of rapamycin (mTOR) inhibitors
(mTORIs) as immunosuppressant and antiproliferative agents have been made. Recent …

Coexistence of Eph receptor B1 and ephrin B2 in port‐wine stain endothelial progenitor cells contributes to clinicopathological vasculature dilatation

W Tan, J Wang, F Zhou, L Gao, R Yin… - British Journal of …, 2017 - academic.oup.com
Background Port‐wine stain (PWS) is a vascular malformation characterized by progressive
dilatation of postcapillary venules, but the molecular pathogenesis remains obscure …

Topical adjuncts to pulsed dye laser for treatment of port wine stains: review of the literature

SR Lipner - Dermatologic Surgery, 2018 - journals.lww.com
BACKGROUND Port wine stains (PWS) pose a therapeutic challenge. Pulsed dye laser
(PDL) is the treatment of choice; however, treatment is often ineffective and recurrences are …

Port wine stain treated with a combination of pulsed dye laser and topical rapamycin ointment

TD Griffin Jr, JP Foshee, R Finney… - Lasers in surgery and …, 2016 - Wiley Online Library
Background and Objective A port wine stain (PWS) is a type of capillary vascular
malformation composed of malformed, dilated blood vessels within the papillary and …

Treatment of port wine stains using pulsed dye laser, erbium YAG Laser, and topical rapamycin (sirolimus)—A randomized controlled trial

K Greveling, EP Prens… - Lasers in Surgery and …, 2017 - Wiley Online Library
Background and Objective Pulsed Dye Laser (PDL) is currently the gold standard treatment
for port wine stains (PWS), although the degree of lesion blanching is variable and often …